This gradual increase helps to minimise side effects and allows the body to adjust to the medication effectively
Over a four-month period from November 1, 2024, to March 12, 2025, I tracked my progress using a 3D body scanner and saw the following changes: This was a significant shift, as many people on GLP-1 medications struggle to maintain muscle mass while losing weight
while protection is demonstrated during active treatment, the long-term effects after stopping are not well established
Drugmakers Eli Lilly and Novo Nordisk are developing oral versions of their GLP-1 medications, which could dramatically lower costs
Work with a coach who actually understands body composition, not just weight loss
"It's like having Reddit and PubMed combined in one clean answer." Amy P